Scholarlink

This chapter describes important points of the common ground, similarities, and differences between the two authoritative documents of research ethics principles: the 2024 Declaration of Helsinki of the World Medical Association and the 2016 International Ethical Guidelines for Health-related Research involving Humans of the Council for International Organizations of Medical Sciences, considering the latest revision of the Declaration of Helsinki, adopted in October 2024. The author has been involved in the previous revisions of both documents since the 1990s. While there have been plentiful discussions about them, some points deserve in-depth consideration. This chapter highlights new items and controversial points in the 2024 revision of the Declaration of Helsinki, namely, good governance practice of research teams or institutions, community engagement and vulnerability, research waste and social value, and placebo-controlled trials.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Bridging Between the CIOMS and the WMA: Common Ground, Similarities, Differences, and Next Steps

  • 章节

  • 发表日期：

    2025年

查看全文
  • Dominique Sprumont

摘要

This chapter describes important points of the common ground, similarities, and differences between the two authoritative documents of research ethics principles: the 2024 Declaration of Helsinki of the World Medical Association and the 2016 International Ethical Guidelines for Health-related Research involving Humans of the Council for International Organizations of Medical Sciences, considering the latest revision of the Declaration of Helsinki, adopted in October 2024. The author has been involved in the previous revisions of both documents since the 1990s. While there have been plentiful discussions about them, some points deserve in-depth consideration. This chapter highlights new items and controversial points in the 2024 revision of the Declaration of Helsinki, namely, good governance practice of research teams or institutions, community engagement and vulnerability, research waste and social value, and placebo-controlled trials.